Epoch Investment Partners’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-99,461
Closed -$7.34M 444
2022
Q1
$7.34M Hold
99,461
0.04% 300
2021
Q4
$7.18M Buy
99,461
+2,372
+2% +$172K 0.04% 297
2021
Q3
$7.44M Hold
97,089
0.04% 290
2021
Q2
$7.53M Buy
97,089
+17,987
+23% +$1.28M 0.04% 285
2021
Q1
$4.88M Buy
79,102
+4,104
+5% +$260K 0.02% 279
2020
Q4
$4.89M Buy
74,998
+3,896
+5% +$224K 0.02% 279
2020
Q3
$3.52M Sell
71,102
-204,374
-74% -$10.5M 0.02% 262
2020
Q2
$13.1M Sell
275,476
-238,248
-46% -$11.5M 0.07% 193
2020
Q1
$21.8M Buy
513,724
+356,112
+226% +$17.6M 0.13% 141
2019
Q4
$9.28M Sell
157,612
-27,195
-15% -$1.48M 0.04% 226
2019
Q3
$9.45M Buy
+184,807
New +$8.8M 0.04% 200

Other funds holding GMED

Epoch Investment Partners's GMED Position: Q2 2022 in Review

Epoch Investment Partners sold out of Globus Medical (GMED) in Q2 2022, closing a stake of 99,461 shares — an estimated $7.34M sold.

Epoch Investment Partners first reported a position in GMED in Q3 2019 and held it in 11 quarters. The position peaked at $21.8M in Q1 2020. 364 funds tracked by Wall St. Rank hold GMED as of Q2 2022.

  • Epoch Investment Partners reported no remaining Globus Medical position as of Q2 2022 after selling out during the quarter.
  • Epoch Investment Partners sold 99,461 Globus Medical shares in Q2 2022, an estimated $7.34M.
  • Epoch Investment Partners first reported a position in Globus Medical in Q3 2019 and held it in 11 quarters.
  • Epoch Investment Partners's Globus Medical position peaked at $21.8M in Q1 2020.
  • 364 funds tracked by Wall St. Rank held Globus Medical as of Q2 2022.

Based on Epoch Investment Partners's 13F filing for Q2 2022, filed 15 Aug 2022.